Top Tech Companies (144)
We are a global manufacturer of raw materials and a producer of energy used in everyday life. From medicines to mobile phones, agriculture to automotive, our products enhance standards of living for everyone around the world. We understand the challenge the world is facing, and we are working hard to help economies, businesses and individuals deliver a zero carbon emissions...
Complement Therapeutics GmbH (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade. Our lead investigational product (CTx001) is being evaluated as a potential gene...
Phastar is a specialist biometrics contract research organization offering statistical consulting, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements and preferred partnerships. Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilizes internal processes designed to guarantee optimal...
We started Samphire Neuroscience to build a world where women everywhere have access to scientifically validated wearable technology for their health needs, without having to sacrifice on technology, design or lifestyle. Building on more than thirty years of research and clinical experience, we are developing wearable neurotechnology, the Samphire Headband, that addresses a range of menstrual-cycle related challenges. Want to know more?...
Our team of scientists and product experts are on a mission: developing Sensory Intelligence to seamlessly anchor machines into physical reality. Exciting things are in the pipeline... Stay tuned! #SensoryIntelligence #FutureOfMachines
Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he...
At Touchlight we are revolutionising DNA. Our Company and technology is built on the conviction that DNA is fundamental to the future of medicine. By moving away from today's restrictive biological approaches, we have made DNA simple. Our unique dbDNA™ (or "doggybone" DNA) vector is optimised for use in advanced genetic medicines, being safer and more efficacious than conventional plasmid DNA....
We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets.
We are a pioneering healthcare company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in...
Wellcome supports science to solve the urgent health challenges facing everyone. We’re a global charitable foundation. And we want everyone to benefit from science’s potential to improve health and save lives. We support discovery research into life, health and wellbeing, and we’re taking on three worldwide health challenges: mental health, climate and health and infectious diseases. Ask us questions, comment on posts...
Hurdle's mission is clear: democratize access to biology for companies and consumers by creating cutting-edge bio-infrastructure. Harnessing deep expertise, our tech-driven platform integrates easily with any business system. With its modular and end-to-end capabilities, Hurdle ensures biology data is not only accessible but also actionable, breaking down the traditional barriers. We're more than just a platform; we're catalysts for change....
SIME is a clinical AI company applying medical excellence, proprietary AI and data ingenuity to deliver rapid respiratory intensive care diagnostics for acute unmet needs. Our clinically proven technology enables early intervention in life-threatening diseases - improving outcomes and reducing costs.
Winner of the 2022 Prix Galien UK Award for "Best Digital Health Solution". The equivalent of the Nobel Prize within Life Science. At behold.ai we utilise cutting-edge science to pioneer new forms of diagnostic medicine; this revolutionary approach to healthcare is a step change in the treatment and prevention of diseases, benefiting patients on a global scale
Princeton Biopartners is a best-in-class provider of integrated consulting solutions to the life sciences sector. Our mission is to improve the evidence base, accessibility, and impact of biomedical innovations through strategic advisory, software, and our venture fund. We pride ourselves on establishing long-term client relationships and are dedicated to addressing pain points via integrated and transformative projects. Setting new standards...
Hidden within our planet's vast biodiversity are solutions to some of humanity's greatest challenges, with the potential to deliver sustainable food supplies, revolutionary manufacturing capabilities, and a new generation of medicines. At Basecamp Research, we are building BaseDiscovery, a platform technology that will use next-gen DNA analysis and environmental monitoring to connect the dots and improve our understanding of the...
Synthace is a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. It allows biologists to design, plan, and automate experiments in a single place, then automatically gather structured experiment data and metadata in a unified no-code environment.
Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI and machine learning analytics
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business...
We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with...
